456
Views
25
CrossRef citations to date
0
Altmetric
Research Article

Comparative studies on glycerol monooleate- and phytantriol-based cubosomes containing oridonin in vitro and in vivo

, , , , , , , , , & show all
Pages 322-329 | Received 14 May 2015, Accepted 02 Nov 2015, Published online: 16 Dec 2015

References

  • Bae S, Lee E-J, Lee JH, et al. Oridonin protects HaCaT keratinocytes against hydrogen peroxide-induced oxidative stress by altering microRNA expression. Int J Mol Med 2014;33:185–193.
  • Guo W, Zheng P, Zhang J, et al. Oridonin suppresses transplant rejection by depleting T cells from the periphery. Int Immunopharmacol 2013;17:1148–1154.
  • Yang R, Huang X, Dou J, et al. Self-microemulsifying drug delivery system for improved oral bioavailability of oleanolic acid: design and evaluation. Int J Nanomedicine 2013;8:2917–2926.
  • Qi X, Zhang D, Xu X, et al. Oridonin nanosuspension was more effective than free oridonin on G2/M cell cycle arrest and apoptosis in the human pancreatic cancer PANC-1 cell line. Int J Nanomedicine 2012;7:1793–1804.
  • Wang W, Zhu R, Xie Q, et al. Enhanced bioavailability and efficiency of curcumin for the treatment of asthma by its formulation in solid lipid nanoparticles. Int J Nanomedicine 2012;7:3667–3677.
  • Phan S, Fong W-K, Kirby N, et al. Evaluating the link between self-assembled mesophase structure and drug release. Int J Pharm 2011;421:176–182.
  • de Waard H, De Beer T, Hinrichs WL, et al. Controlled crystallization of the lipophilic drug fenofibrate during freeze-drying: elucidation of the mechanism by in-line Raman spectroscopy. AAPS J 2010;12:569–575.
  • Dian L, Yang Z, Li F, et al. Cubic phase nanoparticles for sustained release of ibuprofen: formulation, characterization, and enhanced bioavailability study. Int J Nanomedicine 2013;8:845–854.
  • Zhang Z, Gao F, Jiang S, et al. Nano-based drug delivery system enhances the oral absorption of lipophilic drugs with extensive presystemic metabolism. Curr Drug Metab 2012;13:1110–1118.
  • Esposito E, Eblovi N, Rasi S, et al. Lipid-based supramolecular systems for topical application: a preformulatory study. AAPS PharmSci 2003;5:62–76.
  • Hartmann P, Lee D-K, Smarsly BM, et al. Mesoporous TiO(2): comparison of classical sol-gel and nanoparticle based photoelectrodes for the water splitting reaction. ACS Nano 2010;4:3147–3154.
  • Boyd BJ, Khoo S-M, Whittaker DV, et al. A lipid-based liquid crystalline matrix that provides sustained release and enhanced oral bioavailability for a model poorly water soluble drug in rats. Int J Pharm 2007;340:52–60.
  • Chang C-M, Bodmeier R. Low viscosity monoglyceride-based drug delivery systems transforming into a highly viscous cubic phase. Int J Pharm 1998;173:51–60.
  • Muller F, Salonen A, Glatter O. Phase behavior of phytantriol/water bicontinuous cubic Pn3m cubosomes stabilized by laponite disc-like particles. J Colloid Interface Sci 2010;342:392–398.
  • Korjamo T, Heikkinen AT, Monkkonen J. Analysis of unstirred water layer in in vitro permeability experiments. J Pharm Sci 2009;98:4469–4479.
  • Swarnakar NK, Thanki K, Jain S. Bicontinuous cubic liquid crystalline nanoparticles for oral delivery of doxorubicin: implications on bioavailability, therapeutic efficacy, and cardiotoxicity. Pharm Res 2014;31:1219–1238.
  • Jain S, Bhankur N, Swarnakar NK, Thanki K. Phytantriol based “stealth” lyotropic liquid crystalline nanoparticles for improved antitumor efficacy and reduced toxicity of docetaxel. Pharm Res 2015;32:1–11.
  • Chang DP, Jankunec M, Barauskas J, et al. Adsorption of lipid liquid crystalline nanoparticles on cationic, hydrophilic, and hydrophobic surfaces. ACS Appl Mater Interfaces 2012;4:2643–2651.
  • Nguyen T-H, Hanley T, Porter CJ, et al. Nanostructured liquid crystalline particles provide long duration sustained-release effect for a poorly water soluble drug after oral administration. J Control Release 2011;153:180–186.
  • Rizwan S, Dong Y-D, Boyd B, et al. Characterisation of bicontinuous cubic liquid crystalline systems of phytantriol and water using cryo field emission scanning electron microscopy (cryo FESEM). Micron 2007;38:478–485.
  • Yang D, Armitage B, Marder SR. Cubic liquid-crystalline nanoparticles. Angew Chem Int Ed Engl 2004;43:4402–4409.
  • Jia L, Shen J, Zhang D, et al. In vitro and in vivo evaluation of oridonin-loaded long circulating nanostructured lipid carriers. Int J Biol Macromol 2012;50:523–529.
  • Gao L, Zhang D, Chen M, et al. Preparation and characterization of an oridonin nanosuspension for solubility and dissolution velocity enhancement. Drug Dev Ind Pharm 2007;33:1332–1339.
  • Hancock BC, Carlson GT, Ladipo DD, et al. Comparison of the mechanical properties of the crystalline and amorphous forms of a drug substance. Int J Pharm 2002;241:73–85.
  • Schoen. Infinite periodic minimal surfaces without self-intersection, NASA Technical Note C-98 (NASA Electronics Research Center, Cambridge, Mass., Sept. 1969); NASA Technical Note 1970;D-5541, Notices of the Amer Math Soc 1969;16;519, 1968;15;929, 1968;15;727, 1967;14;661.
  • Han K, Pan X, Chen M, et al. Phytantriol-based inverted type bicontinuous cubic phase for vascular embolization and drug sustained release. Eur J Pharm Sci 2010;41:692–699.
  • Shah JC, Sadhale Y, Chilukuri DM. Cubic phase gels as drug delivery systems. Adv Drug Deliv Rev 2001;47:229–250.
  • Barry PH, Diamond JM. Effects of unstirred layers on membrane phenomena. Physiol Rev 1984;64:763–872.
  • Larhed AW, Artursson P, Björk E. The influence of intestinal mucus components on the diffusion of drugs. Pharm Res 1998;15:66–71.
  • Barauskas J, Johnsson M, Tiberg F. Self-assembled lipid superstore beyond vesicles and liposomes. Nano Lett 2005;5:1615–1619.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.